Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
Apoptosis : an International Journal on Programmed Cell Death|July 23, 2025
Kim-1-targeted multimodal nanoprobes for early diagnosis and monitoring of sepsis-induced acute kidney injuryQingjie Chen, Jianbo Yang, Mei Yang, et al.
Journal of Oncology|February 21, 2022
A Lipid Metabolism-Based Seven-Gene Signature Correlates with the Clinical Outcome of Lung AdenocarcinomaTianqi Li, Jiquan Chen, Jun Liu, et al.
Chinese Medical Journal|October 16, 2014
Molecular mechanisms of FK506-induced hypertension in solid organ transplantation patientsJianglin Wang, Ren Guo, Shikun Liu, et al.
Frontiers in Oncology|October 15, 2025
Nomogram based on the novel index LANR, composed of preoperative lymphocytes, albumin, and neutrophils, for predicting prognosis in patients with gastric cancer: a retrospective studyRuoyun Li, Qinghua Liu, Haohao Wang, et al.
Biomacromolecules|July 26, 2024
Multifunctional Nanoprobe Au@Gd-SiO<sub>2</sub>-HA-Lyp-1/DOX with Dual-Targeting Functions Derived from HA and LyP-1: Diagnostic and Therapeutic Potential for Tumor Lymphatic MetastasisQingjie Chen, Mengzhi Wan, Lanlan Zhu, et al.
Cancer Cell International|December 9, 2020
Targeted nanobody complex enhanced photodynamic therapy for lung cancer by overcoming tumor microenvironmentQing Zhang, Lian Wu, Shaozheng Liu, et al.
Medical Oncology (Northwood, London, England)|March 28, 2023
Steroidal saponin SSPH I induces ferroptosis in HepG2 cells via regulating iron metabolismDan Huang, Xin Dong, Jianzhe Li, et al.
Lipids in Health and Disease|November 18, 2015
Short-and long-term effects of ischemic postconditioning in STEMI patients: a meta-analysisJing Gao, Junyi Luo, Fen Liu, et al.
Frontiers in Pharmacology|May 13, 2021
Efficacy and Safety of Berberine Alone for Several Metabolic Disorders: A Systematic Review and Meta-Analysis of Randomized Clinical TrialsYu Ye, Xiufen Liu, Ninghua Wu, et al.
Nanotechnology|July 28, 2021
Moderating hypoxia and promoting immunogenic photodynamic therapy by HER-2 nanobody conjugate nanoparticles for ovarian cancer treatmentQing Zhang, Lian Wu, Shaozheng Liu, et al.
Pageof 8